Evidence map›Paper›PMID 42347171›Full record

ReviewPathogens (Basel, Switzerland)2026

Bacteriophage-Based Therapeutics for Bacterial Sexually Transmitted Infections: From Biological Barriers to Translational Strategies.

Nazym Syrym, Bolat Yespembetov, Sabit Kokanov, Aziz Nakhanov, Yerbol Bulatov, Azamat Abdimukhtar, Alinur Toleukhan, Yeldos Serikbay, Aibol Terebay, Aktoty Anarbekova and 7 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Nazym SyrymResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.
Bolat YespembetovResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.
Sabit KokanovResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.
Aziz NakhanovResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-6593-0271
Yerbol BulatovResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0001-8543-4219
Azamat AbdimukhtarResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.
Alinur ToleukhanResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.
Yeldos SerikbayResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.
Aibol TerebayResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.
Aktoty AnarbekovaResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.
Kali TileukhanovResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.
Sabira AlpysbayevaResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.
Makhpal SarmykovaResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.
Bekzat YerzhigitResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.
Nadezhda ZininaResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.
Marat SuleimenovDepartment of Biotechnology and General Chemical Technology, S.D. Asfendiyarov Kazakh National Medical University, Almaty 050000, Kazakhstan.
Akbope AbdykalykResearch Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-1998-8798

Funding

Ministry of Science and Higher Education of the Republic of Kazakhstan AP23489672
6 · The paper itself

Abstract

Bacterial sexually transmitted and sexually associated infections remain a major global health concern, increasingly complicated by antimicrobial resistance and the limited effectiveness of existing therapies. In this context, bacteriophage-based and phage-derived approaches have re-emerged as potential alternative antibacterial strategies. This narrative review examines their applicability across key bacterial pathogens associated with sexually transmitted infections, including

Indexed as

BacteriophagesPhage TherapySexually Transmitted Diseases, BacterialAnti-Bacterial AgentsBiofilmsHumansAnti-Bacterial Agentsantimicrobial resistancebacterial vaginosisbacteriophage therapyChlamydia trachomatisCRISPR-CasendolysinsMycoplasma genitaliumNeisseria gonorrhoeaesexually transmitted infectionsTreponema pallidum

Identifiers

PMID42347171
PMCPMC13304640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.